Tag: AllTrials

Hi @pfizer,

How many closed studies sponsored by Pfizer remain unpublished? How many closed studies sponsored by Pfizer without disclosed results to ClinicalTrials.gov? https://clinicaltrials.gov/ct2/results/displayOpt?flds=a&flds=b&flds=c&submit_fld_opt=on&recr=Closed&lead=Pfizer&show_flds=Y — Pfizer se niega a transparentar datos obtenidos en ensayos clínicos http://t.co/C7qLx7TIn7 — Médicos Sin Marca (@MedicosSinMarca) September 1, 2015 .@Pfizer says greater clinical trial transparency offers no value to patients. They are…

“how about your Pharma mongers peddling trash book deals and selling testimony for litigation $$$$” #Flibanserin (p2)

p1:  aperitīvus This interaction between @pharmagossip and an @SproutPharma supporter is worth a read. http://t.co/Tmyt8LG97i via @Jor_H_R — Matthew Herper (@matthewherper) June 8, 2015 "just shooting the breeze with some new found Twitter friends :) #Flibanserin #femaleviagra” http://t.co/nZtBES8R0F — ben goldacre (@bengoldacre) June 8, 2015 #flibanserin – Twitter is wonderful! http://t.co/lvCothQkqt — pharmagossip (@pharmagossip) June…

Evidence Live 2015: Analysis of US phase 3 ClinicalTrials.gov records completed before January 1st, 2011 (n=5051; time frame: 2002 to 2014).

Introduction (background) There has been a growing concern about the selective reporting of clinical trial results (i.e., publication bias). The problem of unpublished and misreported clinical trials was the main reason behind the creation of campaigns such as AllTrials and The BMJ Open Data Campaign. The birth of clinical trial registers (e.g., ClinicalTrials.gov, EudraCT, ISCRTN,…

A message to people responsible for abandoned or misreported trials: you will be published or retracted | #AllTrials

Re: Restoring invisible and abandoned trials: a call for people to publish the findings Tom Jefferson, et al. 346:doi 10.1136/bmj.f2865 Deadline in this article passed several months ago (June 14, 2014).(1) – People with abandoned trials: you will be published. – People with misreported trials: you will receive several requests of retractions. Please remember that…

Re: Putting GlaxoSmithKline to the test over paroxetine

Dear Editor, Over 70% of paroxetine studies registered at ClinicalTrials.gov (completion date before January 1st, 2011) remain unpublished. This problem is not unique to paroxetine because other blockbuster antidepressants (e.g., fluoxetine and sertraline) have not published over half of their studies.(1) More unpublished paroxetine studies can be identified analyzing data of other registers (e.g., Eudra…

#AllTrials: “Patients’ and doctors’ campaign welcomes plans to tackle unjust and dangerous problem of hidden clinical trials”

Article originally posted on the AllTrials website on November 20th, 2014 (no changes were made). Read this article via AllTrials.net: http://www.alltrials.net/news/patients-and-doctors-campaign-welcomes-plans-to-tackle-unjust-and-dangerous-problem-of-hidden-clinical-trials/ The AllTrials campaign, which has been calling for all clinical trials past and present to be registered, and full methods and results made available, today welcomed new proposals by the US Department of Health and Human Services (HHS) and…

Incretin mimetics: liraglutide (Victoza) unpublished studies (ClinicalTrials.gov, EudraCT, and UMIN) → 69%

  Background: “Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage” – Re: let’s start this discussion again Unpublished & published liraglutide studies in humans – Completed before Jan 1, 2011 – – Unpublished (n=37): 68.5% – Published (n=17): 31.5% → 3.1 papers per published study record. 90% of the studies (35 / 39) were retrospectively registered Median (Interquartile range: Q1…